Showing 1 - 8 results of 8 for search 'T. Decroo', query time: 0.02s
Refine Results
-
1
Are Expert Patients an Untapped Resource for ART Provision in Sub-Saharan Africa? by Tom Decroo, Wim Van Damme, Guy Kegels, Daniel Remartinez, Freya Rasschaert
Published 2012-01-01Get full text
Article -
2
Utilization of and Barriers to HIV and MCH Services among Community ART Group Members and Their Families in Tete, Mozambique by Diederike Geelhoed, Tom Decroo, Sergio Dezembro, Humberto Matias, Faustino Lessitala, Fausto Muzila, Luisa Brumana, Emanuele Capobianco
Published 2013-01-01Get full text
Article -
3
“If your CD4 count lowers, that is when you are similar to a person that is non-existent” A qualitative exploration of perceptions around advanced HIV disease in South Africa by TP Pita, S. Misra, T. Madonsela, A. Tshazi, S. Bosman, I. Ayakaka, E. Vlieghe, T. Decroo, K. Reither, A. van Heerden, T. Gils
Published 2025-07-01Get full text
Article -
4
Underutilisation of GeneXpert devices for TB diagnosis: a missed opportunity by J. Dörfler, O.G. Ravololohanitra, T. Decroo, M.A. Franke, J. Emmrich, G.I. Pasteur, E.A. Harizaka, N. Muller
Published 2025-07-01Get full text
Article -
5
Treatment outcomes of multi-drug-resistant and rifampicin-resistant tuberculosis with and without isolation of nontuberculous mycobacteria between 2018-2021: A retrospective cohort... by Elizabeth Tabitha Abbew, Roger Laryea, Ama Owusuaa Kwakye, Yaw Adusi Poku, Dorcas Obiri-Yeboah, Lutgarde Lynen, Tom Decroo, Leen Rigouts, Natalie Lorent
Published 2025-07-01Get full text
Article -
6
Estimation of therapeutic threshold for tuberculosis using adapted nominal group technique and clinical vignettes in clinical and community settings in Southern Africa by Alfred Kipyegon Keter, Alastair Van Heerden, Tom Decroo, Tom Boyles, Shannon Bosman, Thandanani Madonsela, Lindani Innocent Msimango, Lenika Naiken, Carlos Kiyan, Mashaete Kamele, Irene Ayakaka, Klaus Reither, Bart Karl Mario Jacobs, Lutgarde Lynen
Published 2025-08-01Get full text
Article -
7
Using linezolid as a substitute for the injectable in case of ototoxicity is safer and as effective as all-oral treatment for rifampicin-resistant TB by M.B. Souleymane, T. Decroo, A. Soumana, I.M. Lawan, A.-L.C. Aboubacar, A. Gagara-Issoufou, R.H. Moussa, A-A.A. Kabirou, I. Hamidou, S.H. Moussa, M. Adamou, E. Adehossi, S. Mamadou, B.C. de Jong, L. Rigouts, A. Piubello
Published 2025-08-01Get full text
Article -
8
Clinical best practices for caring for people with expanded resistance to newer TB drugs by T. Nkomo, Z. Udwadia, D. Vambe, A. van Rie, S.S. Thi, J. Stillo, A. Stambekova, A. Sinha, M.L. Rich, A. Reuter, J. Patel, R. Otto-Knapp, I. Motta, A. Mesic, L. McKenna, S. Maru, E. Lessem, C. Lange, N. Kiria, Y. Kherabi, G. Günther, L. Guglielmetti, T. Decroo, L. Chen, A. Ashesh, A. Abubakirov, J. Furin
Published 2025-06-01Get full text
Article